Curative Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 2,800

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $153M

  • Investors
  • 17

Curative General Information

Description

Provider of health insurance services intended to make essential healthcare easier to access for everyone. The company's service offerings include COVID-19 testing through a painless and self-administered oral fluid swab, vaccinations, baseline visits, curative commons, and virtual urgent care, enabling clients to access health insurance by providing unmatched simplicity, enhanced engagement, and cost transparency with a competitive monthly premium.

Contact Information

Website
www.curative.com
Formerly Known As
Snap Genomics Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 900 Congress Avenue
  • Suite 500
  • Austin, TX 78701
  • United States
+1 (855)
Primary Industry
Other Healthcare Services
Other Industries
Life and Health Insurance
Vertical(s)
InsurTech, HealthTech
Corporate Office
  • 900 Congress Avenue
  • Suite 500
  • Austin, TX 78701
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curative Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 28-Nov-2025 $153M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Sep-2020 Completed Startup
To view Curative’s complete valuation and funding history, request access »

Curative Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A7
Series A6
Series A5
Series A4
Series A3
Series A2
Series A1 23,999,800 $0.000010 $0 $0 1x $0 1.79%
Series A 29,553,000 $0.000010 $0.08 $0.08 1x $0.08 2.2%
To view Curative’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Curative Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Curative Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022204017-A1 Immunization assessments using saliva or nasal specimen Inactive 22-Mar-2021
WO-2022198004-A1 Sample collection devices and kits, components, and uses thereof Inactive 19-Mar-2021
US-20240140981-A1 Nucleic acid purification methods using a water-immiscible solvent wash Inactive 29-Dec-2020
WO-2022146960-A1 Nucleic acid purification methods using a water-immiscible solvent wash Inactive 29-Dec-2020
US-20220339623-A1 Devices for determining a target nucleic acid profile and methods of use thereof Inactive 30-Sep-2019 B01L3/5027
To view Curative’s complete patent history, request access »

Curative Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curative Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Duquesne Family Office Family Office Minority
Angel (individual) Minority
Angel (individual) Minority
Resilience Reserve Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Curative Investments & Acquisitions (6)

Curative’s most recent deal was a Early Stage VC with Forta Health for . The deal was made on 17-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Forta Health 17-Jan-2024 Early Stage VC Clinics/Outpatient Services
American Country Insurance 15-Jun-2023 Merger/Acquisition Multi-line Insurance
Wingspan Health 23-Aug-2022 Merger/Acquisition Medical Records Systems
Curative Administrators 01-Dec-2021 Merger/Acquisition Consulting Services (B2B)
Korva Labs 19-May-2020 Merger/Acquisition Laboratory Services (Healthcare)
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Curative Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Wingspan Health San Francisco, CA 2019

Curative FAQs

  • When was Curative founded?

    Curative was founded in 2020.

  • Where is Curative headquartered?

    Curative is headquartered in Austin, TX.

  • What is the size of Curative?

    Curative has 2,800 total employees.

  • What industry is Curative in?

    Curative’s primary industry is Other Healthcare Services.

  • Is Curative a private or public company?

    Curative is a Private company.

  • What is the current valuation of Curative?

    The current valuation of Curative is .

  • What is Curative’s current revenue?

    The current revenue for Curative is .

  • How much funding has Curative raised over time?

    Curative has raised $161M.

  • Who are Curative’s investors?

    , Duquesne Family Office, , , and Resilience Reserve are 5 of 17 investors who have invested in Curative.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process